EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Targeting DNA damage response pathways in tumor drug resistance: Mechanisms, clinical implications, and future directions

Hengzhou Zhu, Yuanyang Tian, Haoyan Chen, Yiyang Qian, Jiahui Li, Dong Niu, Wenyue Zhao, Yulin Wu, Xian Zhang, Tao Tang, Hu Li, Yan-Fang Xian und 2 weitere

Drug Resistance Updates · 2025

DOI: 10.1016/j.drup.2025.101287 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2025. Verfasst von Hengzhou Zhu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, China; School of Chinese Medicine, Faculty of Medic…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neoplasms, DNA Damage, DNA Repair. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 264 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Guangzhou Science and Technology Program Key Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting DNA damage response (DDR) pathways has become a promising strategy for overcoming tumor drug resistance, particularly in cancers with DNA repair defects. DDR pathways, including homologous recombination (HR), non-homologous end joining (NHEJ), base excision repair (BER), and mismatch repair (MMR), are essential for maintaining genomic stability. However, resistance to DDR-targeted therapies, such as PARP inhibitors, often arises due to tumor adaptation through various mechanisms. These include HR pathway restoration, mutations in DDR proteins, altered drug metabolism, and the activation of compensatory repair pathways. This review provides a comprehensive analysis of the molecular mechanisms underlying DDR resistance in tumors and explores the clinical implications of these mechanisms in the context of ongoing therapeutic strategies. We also discuss emerging approaches to overcome DDR resistance, including the development of novel DDR inhibitors, combination therapies, and precision medicine approaches based on biomarkers. Furthermore, we highlight future research directions, focusing on the use of advanced technologies, such as CRISPR screening, single-cell sequencing, and artificial intelligence, to uncover new targets and therapeutic strategies to combat DDR-related drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmNeoplasmsDNA DamageDNA RepairAntineoplastic AgentsHumansPoly(ADP-ribose) Polymerase InhibitorsMolecular Targeted TherapyAnimalsPrecision Medicine

Stichwörter der Autor:innen

DDR pathwaysHR repairPARP inhibitorsPrecision medicineTumor drug resistance

Substanzen

Antineoplastic AgentsPoly(ADP-ribose) Polymerase Inhibitors

Autor:innen und Institutionen

  • Department of Oncology, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, China; School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, NT, Hong Kong, China. Electr…
  • School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, NT, Hong Kong, China. Electronic address: tianyuanyang@link.cuhk.edu.hk.
  • Department of Respiratory, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, China. Electronic address: Haoyanchentcm@126.com.
  • Department of Oncology, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, China. Electronic address: 13338159605@163.com.
  • Department of Oncology, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, China. Electronic address: 2993112293@qq.com.
  • Department of Oncology, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, China. Electronic address: niudong98@163.com.

Förderung

  • National Natural Science Foundation of China
  • Guangzhou Science and Technology Program Key Projects

Zitieren

APA

Zhu, H., Tian, Y., Chen, H., Qian, Y., Li, J., Niu, D., Zhao, W., Wu, Y., Zhang, X., Tang, T., Li, H., Xian, Y. F., Sun, D., & Jin, C. (2025). Targeting DNA damage response pathways in tumor drug resistance: Mechanisms, clinical implications, and future directions. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2025.101287

Vancouver

Zhu H, Tian Y, Chen H, Qian Y, Li J, Niu D, et al. Targeting DNA damage response pathways in tumor drug resistance: Mechanisms, clinical implications, and future directions. Drug Resistance Updates. 2025. doi:10.1016/j.drup.2025.101287

BibTeX
@article{Zhu2025,
  author = {Zhu, Hengzhou and Tian, Yuanyang and Chen, Haoyan and Qian, Yiyang and Li, Jiahui and Niu, Dong and Zhao, Wenyue and Wu, Yulin and Zhang, Xian and Tang, Tao and Li, Hu and Xian, Yan-Fang and Sun, Dongdong and Jin, Chunhui},
  title = {Targeting DNA damage response pathways in tumor drug resistance: Mechanisms, clinical implications, and future directions},
  journal = {Drug Resistance Updates},
  year = {2025},
  doi = {10.1016/j.drup.2025.101287}
}
Kostenlos starten →